Patient education

When to contact your provider

Name: Fifty 410
Address: US
Price range: $$

A simple green, yellow, and red guide to which symptoms are commonly expected, which need a call within a day or two, and which need emergency care now.

How to use this guide

The zones below are a general aid, not a diagnosis. When in doubt, contact your provider — and for anything in the red zone, do not wait for a portal reply.

Keep your medication name and dose to hand when you call, and tell any emergency staff that you take a GLP-1 medication.

The zones

Red: seek emergency care now

Call 911 or go to the nearest emergency department

Severe abdominal pain, especially in the upper abdomen or spreading to the back
Persistent vomiting, or nothing kept down for 24 hours or more
Severe dehydration: extreme dizziness, confusion, very dark urine, or no urination for many hours
Severe upper-abdominal pain with fever or a rapid heartbeat
Severe right upper abdominal pain, fever, or yellowing of the skin or eyes
Severe bloating with an inability to pass gas or stool, cramping, and vomiting
Difficulty breathing, swelling of the face or throat, or a severe rash
Chest pain or severe shortness of breath
Vision changes or severe eye pain
Confusion, seizure, or loss of consciousness
Thoughts of harming yourself

What to do: Call 911 or go to the emergency department immediately. Do not drive yourself if you feel severely unwell.

How to reach us

Non-urgent questions

Use the patient portal or contact support during business hours for general questions about your order or the process.

Yellow-zone symptoms

Contact your provider through the patient portal within 24 to 48 hours so your dose or schedule can be reviewed.

Red-zone symptoms

Call 911 or go to the emergency department. Do not wait for office hours or a portal reply.

Reminders

When in doubt, contact your provider.
Never ignore severe or worsening symptoms.
A simple symptom note helps your provider make decisions.
If you are told to hold a dose, do not restart without provider approval.

References

U.S. Food and Drug Administration. Semaglutide injection prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209637s008lbl.pdf
U.S. Food and Drug Administration. Tirzepatide injection prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215866s004lbl.pdf
U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers